设为首页 加入收藏

TOP

VELETRI (epoprostenol) for Injection
2016-07-17 07:36:52 来源: 作者: 【 】 浏览:337次 评论:0
 
  • HIGHLIGHTS OF PRESCRIBING INFORMATION
    These highlights do not include all the information needed to use VELETRI safely and effectively. See full prescribing information for VELETRI.
    VELETRI (epoprostenol) for Injection
    Initial U.S. Approval: 1995
    INDICATIONS AND USAGE

    VELETRI is a prostanoid vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity. Studies establishing effectiveness included predominantly patients with NYHA Functional Class III-IV symptoms and etiologies of idiopathic or heritable PAH or PAH associated with connective tissue diseases. (1)
    DOSAGE AND ADMINISTRATION

    • Dosage
      -
      Infusion of VELETRI should be initiated at 2 ng/kg/min and increased in increments of 2 ng/kg/min every 15 minutes or longer until dose-limiting pharmacologic effects are elicited or until a tolerance limit to the drug is established. ( 2.1)
      -
      If symptoms of pulmonary hypertension persist or recur after improving - the infusion should be increased by 1- to 2-ng/kg/min increments at intervals sufficient to allow assessment of clinical response; these intervals should be at least 15 minutes. ( 2.2)
    • Administration
      -
      VELETRI is administered by continuous intravenous infusion via a central venous catheter using an ambulatory infusion pump. ( 2.3)
      -
      Do not mix with any other parenteral medications or solutions prior to or during administration. ( 2.4)
      -
      During initiation of treatment, VELETRI may be administered peripherally. ( 2.3)
    • Reconstitution
      -
      Reconstituted in vial with only 5 mL of either Sterile Water for Injection or Sodium Chloride 0.9% Injection. This solution may be refrigerated at 2°C to 8°C (36° to 46°F) for as long as 5 days or held at up to 25°C (77°F) for up to 48 hours prior to use. ( 2.4)
      -
      Reconstituted product should be further diluted as directed with the same diluent used for reconstitution. This solution of 15000 ng/mL or above of VELETRI may be used for up to 24 hours at room temperature. (Lower concentrations may be used with pump reservoir changed every 12 hours when used
      以下是“全球医药”详细资料
  • Tags: 责任编辑:admin
    】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
    分享到QQ空间
    分享到: 
    上一篇AVAPRO®(irbesartan)Tablets 下一篇GILOTRIF (afatinib) tablets

    相关栏目

    最新文章

    图片主题

    热门文章

    推荐文章

    相关文章

    广告位